Genesis’ engineered pig kidney kept patients off dialysis for months, including one record nine-month stretch before a ...

Function Health now lets members feed lab results into ChatGPT, Claude and Perplexity, turning AI answers into ones grounded ...

VHH brings its ‘village’ model to Malaysia, betting that longevity gains only pay off economically if care reaches everyone.

Veradermics posts $819.9m war chest and full slate of late-stage trial data as it races to become first FDA-approved oral ...

Alzheimer’s trial needing 760. For a biotech betting everything on one pill, that’s the good kind of surprise.

USPTO grant strengthens Alterity’s IP position and opens a path for ATH434 into Parkinson’s disease investment.

THPharm already has a drug in late-stage trials. Now it’s using AI to work backwards and find out what else that drug might ...

Longevity is becoming big business, but the science, standards and clinical practices needed to guide the field are still ...

One-year trial results show most patients kept off GLP-1-induced weight loss after a single endoscopic procedure.

Fresh NIH funding backs an iPSC-and-AI push to find drugs for Duchenne cardiomyopathy without relying on mouse models that ...

Seven months after ditching paper screening for Creyos, Claremedica is catching over 90% of new dementia cases at the earliest stage.